期刊文献+

胃癌化疗的新视角 被引量:3

New Insights into Chemotherapy of Gastric Cancer
下载PDF
导出
摘要 胃癌在全球范围内的发病率和死亡率均较高,手术切除是胃癌治疗的首选,化疗的应用日益广泛。对于局部晚期胃癌患者,通过术前新辅助化疗可能达到根治性切除的目的;对于可手术的患者,术后辅助化疗的目的是消灭术后微转移灶,预防肿瘤复发和转移;晚期胃癌患者通过全身化疗可延长总生存期并改善生活质量。本文就胃癌化疗的研究现状作一综述。 Gastric cancer is one of the most common and leading cause of cancer death worldwide. Surgery is the first choice of treatment and chemotherapy has been used widely. The curative resection rate has been increased in patients with locally advanced gastric cancer after preoperative neoadjuvant chemotherapy. Adjuvant chemotherapy after radical operation of gastric cancer may prevent postoperative micrometastasis, thereby may decrease relapse and metastasis. Patients with advanced gastric cancer could benefit fi'om chemotherapy with improvement in overall survival and quality of life. In this article, we reviewed the current status of chemotherapy of gastric cancer.
出处 《胃肠病学》 2009年第3期188-190,共3页 Chinese Journal of Gastroenterology
关键词 胃肿瘤 化疗方案 抗肿瘤 肿瘤辅助疗法 Stomach Neoplasms Chemotherapy Protocols, Antineoplastic Neoadjuvant Therapy
  • 相关文献

参考文献18

  • 1Frei E 3rd. What's in a name - neoadjuvant. J Natl Cancer Inst, 1988, 80 (14): 1088-1089.
  • 2Cunningham D, Allum WH, Stenning SP, et al, MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355 (1): 11-20.
  • 3Boige V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. 2007 ASCO Annual Meeting Proceedings Part Ⅰ. J Clin Oncol, 2007, 25 (18 Suppl): A4510.
  • 4Hermans J, Bonenkamp J J, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol, 1993, 11 (8): 1441-1447.
  • 5Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer, 1999, 35 (7): 1059-1064.
  • 6Mari E, Floriani I, Tinazzi A, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo haliano per lo Studio dei Careinomi dell'Apparato Digerente). Ann Oncol, 2000, 11 (7): 837-843.
  • 7Panzini I, Gianni L, Fattori PP, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta- analyses. Tumori, 2002, 88 (1): 21-27.
  • 8Liu TS, Wang Y, Chen SY, et al. An updated meta- analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol, 2008, 34 (11): 1208-1216.
  • 9Sakuramoto S, Sasako M, Yamaguchi T, et al. ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med, 2007, 357 (18): 1810-1820.
  • 10Fujimoto S, Takahashi M, Mutou T, et al. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 1999,85 (3): 529-534.

同被引文献13

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部